Tag Archives: Breyanzi

CAR-T Cell Therapy Cancer Risks May Drop Off After Two Weeks of Therapy: Study

August 15, 2024 By: Tyler New

Earlier this year the FDA required six CAR-T drug manufacturers to add secondary cancer warnings to drug labeling, and recommended life-long cancer screenings for patients.
FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

January 26, 2024 By: Irvin Jackson

Genetic sequencing appears to confirm that some cases of cancer have a direct connection to CAR-T cell transgenes used in the medications, the FDA reports.
FDA Requires CAR-T Cancer Warnings Be Added For All Drugs in the Class

January 24, 2024 By: Irvin Jackson

Cancerous tumors can develop within weeks after receiving CAR-T drug infusions, some of which can be fatal, the FDA warns.

AngioDynamics Port Catheter Lawyers Seek Leadership Roles in MDL (Posted 5 days ago)

A proposal has been submitted for a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions in the litigation, which involves dozens of claims that the implants were defectively designed, leading to fractures, migration and infections.

Future of Suboxone Lawsuits Taken Under Advisement After Motion To Dismiss Arguments (Posted 5 days ago)

Judge overseeing all Suboxone tooth decay lawsuits brought in the federal court system heard oral arguments this week, and is considering whether the claims should be preempted by federal law.

Ozempic NAION Vision Loss Risks Confirmed in Another Study (Posted 6 days ago)

A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

Tag Archives: Breyanzi

CAR-T Cell Therapy Cancer Risks May Drop Off After Two Weeks of Therapy: Study

FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

FDA Requires CAR-T Cancer Warnings Be Added For All Drugs in the Class

More Top Stories

Review A Case